Home/ Supplements/ Ginkgo/ Ginkgo Biloba

Ginkgo Biloba

product on market Tablet or Pill 365 Everyday Value Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Ginkgo biloba is researched for its potential to support cognitive function and circulation. However, clinical evidence for these effects is generally considered limited or mixed. This ingredient profile maintains a high safety score, indicating a low risk of adverse effects for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ginkgo Biloba
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 120.0mg (440 products) 191 studies (A:1, B:71)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium Silicon Dioxide Magnesium Stearate Food Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 tablet, two times daily between meals.

Warnings & Precautions

Tamper evident; use only if seal is intact.

Note: If you are pregnant or lactating, consult your health care practitioner before using this product.

Keep out of reach of children.

Formulation Notes

Vegetarian

Contains no artificial colors, flavors or preservatives.

Additional Information

241225 401241225-A

(recycle) HDPE

PLEASE RECYCLE THIS BOTTLE

100% PCR Post Consumer Recycled Bottle

Improve Circulation and Memory

Good Manufacturing Practices used to segregate ingredients in a facility that also processes milk, egg, fish, shellfish, tree nut, wheat and soybeans in its manufacturing process.

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 99482 41225 8
DSLD Entry Date2012-08-24
Product TypeBotanical
FormTablet or Pill
DSLD ID12022
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.